Clinical trial
A Phase II Trial of Pemetrexed in Combination With Gemcitabine as First Line Treatment in Extensive-Stage Small Cell Lung Carcinoma
NCT00129974 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Pemetrexed in Combination With Gemcitabine as First Line Treatment in Extensive-Stage Small Cell Lung Carcinoma
- Lead sponsor
- Tufts Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 31, 2005
- Completion date
- October 31, 2006
- Enrollment
- 1 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.